Track the 명문제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 명문제약 has recorded 81 public disclosures. Market capitalisation: €44.1bn. The latest transaction was disclosed on 11 June 2026 (Purchase). Among the most active insiders: 우석민. Every trade is openly available.
77
Insider Decl.
n/a
Thresholds
€11,558
62 ops.
Buy Volume
n/a
n/a
Sell Volume
3Σ signal
Buys €11,558n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,073 of 29,062 companies
36.6
score / 100
Value
39
Quality
34
FCF yld-19%
Earn yld4.3%
EV/EBITDA12.2x
ROE-2.5%
Gross mgn55%
Net mgn1.0%
Debt/EBITDA8.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.